Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Shares Issued
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock - Number of Shares, Treasury Shares
Common Stock - Number of Shares, Treasury Shares
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance at beginning of period at Dec. 31, 2019 $ 563,268     $ 33   $ (116,515)   $ 575,816   $ 3,382   $ 100,552    
Balance at beginning of period (ASU 2016-13) at Dec. 31, 2019   $ (12,167)                     $ (12,167)  
Beginning balance, shares issued (shares) at Dec. 31, 2019       33,475,402 33,475,402                  
Beginning balance, treasury stock (shares) at Dec. 31, 2019           (2,675,778) (2,675,778)              
Beginning balance, shares outstanding (shares) at Dec. 31, 2019       30,799,624 30,799,624                  
Adjusted balance at Dec. 31, 2019     $ 551,101   $ 33   $ (116,515)   $ 575,816   $ 3,382     $ 88,385
Restricted stock awards, net of forfeitures (shares)       20,511                    
Share-based compensation expense 1,395             1,395            
Restricted stock surrendered due to employee tax liability (291)         $ (291)                
Restricted stock surrendered due to employee tax liability (shares)       (27,106)   (27,106)                
Repurchase of common stock (2,196)         $ (2,196)                
Repurchase of common stock (shares)       (135,400)   (135,400)                
Cash dividends declared (common stock, $0.12/share, $0.12/share, $0.36/share, $0.22/share) (11,052)                     (11,052)    
Net income 11,526                     11,526    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (3,047)                 (3,047)        
Balance at end of period at Jun. 30, 2020 547,436     $ 33   $ (119,002)   577,211   335   88,859    
Ending balance, shares issued (shares) at Jun. 30, 2020       33,495,913                    
Ending balance, treasury stock (shares) at Jun. 30, 2020           (2,838,284)                
Ending balance, shares outstanding (shares) at Jun. 30, 2020       30,657,629                    
Balance at beginning of period at Mar. 31, 2020 552,958     $ 33   $ (118,882)   576,585   11,867   83,355    
Beginning balance, shares issued (shares) at Mar. 31, 2020       33,448,214                    
Beginning balance, treasury stock (shares) at Mar. 31, 2020           (2,825,473)                
Beginning balance, shares outstanding (shares) at Mar. 31, 2020       30,622,741                    
Restricted stock awards, net of forfeitures (shares)       47,699                    
Share-based compensation expense 626             626            
Restricted stock surrendered due to employee tax liability (120)         $ (120)                
Restricted stock surrendered due to employee tax liability (shares)       (12,811)   (12,811)                
Cash dividends declared (common stock, $0.12/share, $0.12/share, $0.36/share, $0.22/share) (3,671)                     (3,671)    
Net income 9,175                     9,175    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (11,532)                 (11,532)        
Balance at end of period at Jun. 30, 2020 547,436     $ 33   $ (119,002)   577,211   335   88,859    
Ending balance, shares issued (shares) at Jun. 30, 2020       33,495,913                    
Ending balance, treasury stock (shares) at Jun. 30, 2020           (2,838,284)                
Ending balance, shares outstanding (shares) at Jun. 30, 2020       30,657,629                    
Balance at beginning of period at Dec. 31, 2020 $ 577,044     $ 33   $ (119,046)   578,360   3,076   114,621    
Beginning balance, shares issued (shares) at Dec. 31, 2020       33,560,801                    
Beginning balance, treasury stock (shares) at Dec. 31, 2020 (2,842,966)         (2,842,966)                
Beginning balance, shares outstanding (shares) at Dec. 31, 2020       30,717,835                    
Restricted stock awards, net of forfeitures (shares)       56,510                    
Share-based compensation expense $ 1,235             1,235            
Restricted stock surrendered due to employee tax liability (451)         $ (451)                
Restricted stock surrendered due to employee tax liability (shares)       (21,693)   (21,693)                
Repurchase of common stock (946)         $ (946)                
Repurchase of common stock (shares)       (55,000)   (55,000)                
Cash dividends declared (common stock, $0.12/share, $0.12/share, $0.36/share, $0.22/share) (6,751)                     (6,751)    
Net income 38,781                     38,781    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (5,935)                 (5,935)        
Balance at end of period at Jun. 30, 2021 $ 602,977     $ 33   $ (120,443)   579,595   (2,859)   146,651    
Ending balance, shares issued (shares) at Jun. 30, 2021       33,617,311                    
Ending balance, treasury stock (shares) at Jun. 30, 2021 (2,919,659)         (2,919,659)                
Ending balance, shares outstanding (shares) at Jun. 30, 2021       30,697,652                    
Balance at beginning of period at Mar. 31, 2021 $ 581,822     $ 33   $ (120,087)   578,958   (5,293)   128,211    
Beginning balance, shares issued (shares) at Mar. 31, 2021       33,585,181                    
Beginning balance, treasury stock (shares) at Mar. 31, 2021           (2,902,648)                
Beginning balance, shares outstanding (shares) at Mar. 31, 2021       30,682,533                    
Restricted stock awards, net of forfeitures (shares)       32,130                    
Share-based compensation expense 637             637            
Restricted stock surrendered due to employee tax liability (356)         $ (356)                
Restricted stock surrendered due to employee tax liability (shares)       (17,011)   (17,011)                
Cash dividends declared (common stock, $0.12/share, $0.12/share, $0.36/share, $0.22/share) (3,682)                     (3,682)    
Net income 22,122                     22,122    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 2,434                 2,434        
Balance at end of period at Jun. 30, 2021 $ 602,977     $ 33   $ (120,443)   $ 579,595   $ (2,859)   $ 146,651    
Ending balance, shares issued (shares) at Jun. 30, 2021       33,617,311                    
Ending balance, treasury stock (shares) at Jun. 30, 2021 (2,919,659)         (2,919,659)                
Ending balance, shares outstanding (shares) at Jun. 30, 2021       30,697,652